Menopause
Guidelines
New stroke guidelines focus on women’s risks
News
Romosozumab boosts bone density while cutting resorption
Major finding: Women who received the highest monthly dose of romosozumab showed a mean increase in BMD of 11.3% at the lumbar spine, 4.1% at the...
Cases in Menopause
When should a menopausal woman discontinue hormone therapy?
Although this question is common in clinical practice, the answer isn’t clear-cut
Expert Commentary
Is one oral estrogen formulation safer than another for menopausal women?
YES. Women using estradiol had a lower risk of incident venous thromboembolism than women using conjugated equine estrogens (CEE), according to...
Commentary
Don't tell patients estrogens are "bad"
In vitro fertilization and preimplantation genetic testing should be offered
News
No survival benefit to bisphosphonate in chemoresistant breast cancer
News
FDA rejects flibanserin for low libido in women
Expert Commentary
STOP enforcing a 5-year rule for menopausal hormone therapy
START individualizing therapy to optimize health and quality of life
News
Screening yields long-term reduction in CRC mortality
Major finding: After 30 years, participants who had been screened annually and biennially had respective 32% and 22% reductions in colorectal...
From the Editor
Osteoporosis treatment and breast cancer prevention: Two goals, one treatment?
For postmenopausal women with newly diagnosed osteoporosis, assessing the risk of breast cancer prior to prescribing a bone medicine could...
News
Hormone therapy’s protection against endometrial cancer persists in Women’s Health Initiative follow-up study
Major finding: HT was associated with a 35% reduction in the risk for endometrial cancer (P = .007) when compared with placebo.Data source: The...